BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27760559)

  • 21. The influence of sentinel lymph node biopsy on survival for intermediate-thickness melanoma.
    Kachare SD; Brinkley J; Wong JH; Vohra NA; Zervos EE; Fitzgerald TL
    Ann Surg Oncol; 2014 Oct; 21(11):3377-85. PubMed ID: 25063010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Older Age is Associated with a Higher Incidence of Melanoma Death but a Lower Incidence of Sentinel Lymph Node Metastasis in the SEER Databases (2003-2011).
    Cavanaugh-Hussey MW; Mu EW; Kang S; Balch CM; Wang T
    Ann Surg Oncol; 2015 Jul; 22(7):2120-6. PubMed ID: 25940571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological characteristics at primary melanoma diagnosis as risk factors for brain metastasis.
    Qian M; Ma MW; Fleming NH; Lackaye DJ; Hernando E; Osman I; Shao Y
    Melanoma Res; 2013 Dec; 23(6):461-7. PubMed ID: 24165034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer.
    Park IH; Kong SY; Ro JY; Kwon Y; Kang JH; Mo HJ; Jung SY; Lee S; Lee KS; Kang HS; Lee E; Joo J; Ro J
    Clin Breast Cancer; 2016 Feb; 16(1):51-8. PubMed ID: 26364145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status.
    Michael-Robinson JM; Pandeya N; Cummings MC; Walsh MD; Young JP; Leggett BA; Purdie DM; Jass JR; Radford-Smith GL
    J Pathol; 2003 Sep; 201(1):46-54. PubMed ID: 12950016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-infiltrating lymphocytes and their significance in melanoma prognosis.
    Schatton T; Scolyer RA; Thompson JF; Mihm MC
    Methods Mol Biol; 2014; 1102():287-324. PubMed ID: 24258985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions.
    Hussein MR; Elsers DA; Fadel SA; Omar AE
    J Clin Pathol; 2006 Mar; 59(3):316-24. PubMed ID: 16505286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The characterization and potential impact of melanoma cases with unknown thickness in the United States' Surveillance, Epidemiology, and End Results Program, 1989-2008.
    Shaikh WR; Weinstock MA; Halpern AC; Oliveria SA; Geller AC; Dusza SW
    Cancer Epidemiol; 2013 Feb; 37(1):64-70. PubMed ID: 22995853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma.
    Miracco C; Mourmouras V; Biagioli M; Rubegni P; Mannucci S; Monciatti I; Cosci E; Tosi P; Luzi P
    Oncol Rep; 2007 Nov; 18(5):1115-22. PubMed ID: 17914561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
    Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
    Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma.
    Darb-Esfahani S; Kunze CA; Kulbe H; Sehouli J; Wienert S; Lindner J; Budczies J; Bockmayr M; Dietel M; Denkert C; Braicu I; Jöhrens K
    Oncotarget; 2016 Jan; 7(2):1486-99. PubMed ID: 26625204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response.
    Mihm MC; Clemente CG; Cascinelli N
    Lab Invest; 1996 Jan; 74(1):43-7. PubMed ID: 8569196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor infiltrating lymphocyte clusters are associated with response to immune checkpoint inhibition in BRAF V600
    Klein S; Mauch C; Brinker K; Noh KW; Knez S; Büttner R; Quaas A; Helbig D
    Sci Rep; 2021 Jan; 11(1):1834. PubMed ID: 33469107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased NY-ESO-1 expression and reduced infiltrating CD3+ T cells in cutaneous melanoma.
    Giavina-Bianchi M; Giavina-Bianchi P; Sotto MN; Muzikansky A; Kalil J; Festa-Neto C; Duncan LM
    J Immunol Res; 2015; 2015():761378. PubMed ID: 25954764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased tumor-infiltrating lymphocytes in nodular melanomas compared with matched superficial spreading melanomas.
    Lin RL; Wang TJ; Joyce CJ; Mihm MC; Murphy GF; Lian CG; Lin JY
    Melanoma Res; 2016 Oct; 26(5):524-7. PubMed ID: 26974966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas.
    de Moll EH; Fu Y; Qian Y; Perkins SH; Wieder S; Gnjatic S; Remark R; Bernardo SG; Moskalenko M; Yao J; Ferringer T; Chang R; Chipuk J; Horst BA; Birge MB; Phelps RG; Saenger YM
    Cancer Immunol Immunother; 2015 Sep; 64(9):1193-203. PubMed ID: 26076664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of clinical prognosis in cutaneous melanoma using an immune-related gene pair signature.
    Yang Y; Long X; Li G; Yu X; Liu Y; Li K; Tian X
    Bioengineered; 2021 Dec; 12(1):1803-1812. PubMed ID: 34047683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction.
    Hom SS; Topalian SL; Simonis T; Mancini M; Rosenberg SA
    J Immunother (1991); 1991 Jun; 10(3):153-64. PubMed ID: 1868040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
    Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL
    J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgery vs. radiotherapy in patients with uveal melanoma : Analysis of the SEER database using propensity score matching and weighting.
    Jang BS; Chang JH; Oh S; Lim YJ; Kim IH
    Strahlenther Onkol; 2017 Nov; 193(11):931-942. PubMed ID: 28879443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.